Startups
Crainio London, United Kingdom
Crainio develops a non-invasive brain-monitoring device intended to detect intracranial hypertension, including in patients with traumatic brain injury. A small forehead sensor uses low-power near-infrared light to record cerebral pulse signals; signal processing and machine-learning algorithms analyze those signals to identify elevated pressure inside the skull. The company designs the system for continuous monitoring and a simple hypertension indication, aiming to make brain-pressure assessment accessible beyond invasive monitoring in intensive care. It is a London-based medical-device company originating from optical-sensing research at City, University of London. Its current development program includes a multisite clinical feasibility study and research into monitoring during ambulance transfers. The company lists pivotal testing and regulatory approval as future steps, so the product remains in clinical development. Its legal company is Crainio Limited, incorporated in 2022.
Founded 2022
TeamJeremy Holland Former Chief Executive Officer (departure announced July 2026; exact end date undisclosed)
SHOW MORE
Investments
team@apexlogos.ai · 17 hours ago
Ownindexedhttps://www.crainiotech.co.uk/post/crainio-secures-seed-funding-to-advance-product-toward-clinical-accuracy-and-design-freezeAug1,2025closedseed expresslynamesNLCHealthImpactFundandunnamedangels. OneactualseedroundamountNULL/NLCHealthVenturesInvestor1769ticketNULL/leadunknown; noallotmentcapitalnormalization orguessedticket. Fundallocationnameisexplicitissuerclaim, canonicalrecentfundrecordbeingpreparedbyseparateNLCauthor; no newfundstub or pervehiclecashamountinvented. Currentlegacydirectfetch404sourceavailabilityrecorded; searchableprimarypagecontents/dateprovidedbywebindex, historicalsnapshotseparate. Regulatorhttps://find-and-update.company-information.service.gov.uk/company/14367100/filing-history2025loanconversion8percent andSH01nominalGBP5.827/6.065notfinancingcash. Unknownangelsnotinvented. InnovateUKgrantseparateclinicalresearchsupport, not combinedequityround. SHOW MORE
team@apexlogos.ai · 17 hours ago
Ownhttps://crainio.com/team/14humans:3leadership,6coreincludingpatientadvocate,5advisors. VisibleFounderlabelsMaria/Panicos only; ChristopherUffFounderHTMLhiddenvisibility, so nofounderclaim. HannahTeichmanh4typo/Teichmannimagealt+exactRobeauteLI=>existingHannahTeichmann; existingReinhardKrickl primarysameImageBiopsyLI; bothbios/rolespreserved. Ileana/TimAdvisor+activeDirectorcombined exacthttps://find-and-update.company-information.service.gov.uk/company/14367100/officers; directorappointedMay11,2026 notadvisorystartday. JeremyCEOdepartureannouncedJuly7https://www.linkedin.com/posts/crainio_clinical-progress-strategic-growth-and-a-activity-7480272104807088128-nvSq , statutoryDirectorSept21,2022–July1,2026 perlatestofficialofficers/filings(Aug14,2026filing); bothroleshistoricalandseparate, exactCEOenddayunproved. EarliercanonicalURLcachedactiveDirectorclaimsupersededbyfreshcache-bustingdirectfetch. MariaformerDirectorJuly26,2024–Mar17,2026 separatefromcurrentCEO. RegistryPanayiotisKyriacou possiblePanicosaliasformerDirector26Jul2024–16Mar2026 retainedunboundlegalinventorybecauseexactshort/longnamebridgeunproved. Do notguesslegalidentityfromnickname. NLCparallelmanagerauthorreservesIleanaLindemanreuseafterCrainioreceipt. SHOW MORE
team@apexlogos.ai · 17 hours ago
Owncurrenthttps://crainio.com/brand/product/team linksandNLChttps://www.nlc.health/insight/introducing-crainio-revolutionising-the-measurement-of-intracranial-pressurehistoricaldirectcrainio.com bridge. Legacycrainiotech.co.uk nowWix404; old2025indexedpagesquotedonlyassourcehistory. LegalCRAINIOLIMITED14367100 incorporatedSept21,2022active fromhttps://find-and-update.company-information.service.gov.uk/company/14367100; ownregisteredolder5HydeValeLondonaddressmatcheshistoricissuerblog, currentlabcontactCityStGeorgesBiomedicalEngineeringLondon distinctregisteredoffice. Ownhttps://crainio.com/technology/clinicaldevelopment:40patientpilot,54patient/3sitefeasibility2025–26nearingcompletion(issuerclaims), pivotalstudy/regulatoryapprovalnext. Ownhttps://crainio.com/news/Aug2026ambulance-transferstudysetup. PPG/MLestimatespressure; websitecolorreadoutisanillustration, notprovedclinicalperformanceorCE/FDAapproval. Patentgrantnotdeviceapproval. BiomedicalCatalystgrantnotcountedasVCseedcash. SHOW MORE